Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • Contact

Modest Oklahoma investments lead to innovation

    Home News Modest Oklahoma investments lead to innovation
    NextPrevious

    Modest Oklahoma investments lead to innovation

    By sarah | News | 0 comment | 6 December, 2016 | 0

    Modest Oklahoma investments lead to innovation

    By Scott Meacham
    Copyright 2016, © The Oklahoma Publishing Company

    Most of us have probably read to ourselves, our children or our grandchildren that all-time favorite, “The Little Engine that Could.” This simple tale has been teaching the value of optimism and hard work to millions of young (and old) readers for more than a hundred years.

    Several powerful locomotives are asked to pull a heavy string of cars over a mountain. They each have “good” reasons for why they can’t. The last engine in the yard is a small fellow — not nearly as big or seemingly as powerful as the larger engines.

    With the mantra of “I think I can, I think I can,” that little engine successfully drags the long heavy train over the mountain to deliver Christmas toys to girls and boys.

    That’s how I think of Oklahoma Medical Research Foundation (OMRF) — as that tenacious little engine that could.

    OMRF may seem modest compared to some of the mega research institutions and university facilities across the country and around the world. Yet look at the transformative discoveries and successful companies that have come out of this nonprofit biomedical research institution.

    Crescendo Bioscience, a molecular diagnostics company in South San Francisco acquired by Myriad Genetics for more than $270 million; Alexion a $30-plus billion business in Connecticut, and most recently Selexys, with stunning patient results from breakthrough therapies for treating sickle cell disease discovered by OMRF’s tenacious Rodger McEver, M.D., acquired this month by Novartis for up to $650 million or more.

    “We have smart scientists, but their expertise is discovery and invention,” said OMRF President Stephen Prescott, M.D. “Formulation and toxicology are areas we don’t have and need to partner with when our scientists discover something that feels relevant, we find the right commercialization people and companies to partner with. We’ve got to have the mindset of forming partnerships and knocking down barriers.”

    OMRF’s mindset toward commercialization is their secret sauce. “The origins of that is in our original motto from 70 years ago, that more may live longer and healthier lives,” Prescott said.

    OMRF combines the best elements of academia, encouraging scientists to roam freely with imagination to increase (in Prescott’s words) the chance of productive collisions — with the power of the corporate lab — organizing so that people working in the same area trying to solve the same problems form a critical mass of thinkers who talk and help each other, bouncing ideas rather than being separated in silos typically seen in academic environments.

    “Crescendo and Alexion succeeded elsewhere,” Prescott said. “Selexys was done here with local technology and local talent. The Oklahomans who put early money into the company will be rewarded. That gives potential investors and researchers the confidence that we can do it again.”

    And that brings me back to the little engine, whose mantra at the end of the story was “I thought I could; I thought I could.”

    By some measures, OMRF may be a “little engine.”

    In my mind, it’s a force of nature. There’s no doubt that they think they can — as they have proved over and over.

    Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology and is an integral part of Oklahoma’s Innovation Model. Contact Meacham at i2E_Comments@i2E.org.

    Read the story at newsok.com

    OMRF, Scott Meacham, Selexys Pharmaceuticals

    Related Post

    • A big idea creates ripples that last for decades

      By sarah | Comments are Closed

      By Scott Meacham A big idea creates ripples that can be felt decades later. Entrepreneurship is like tossing a rock into a pond. The rock gives the water energy to create ever-widening rippling circles. AsRead more

    • There’s no single path to entrepreneurial success

      By sarah | Comments are Closed

      By Scott Meacham There is no single path to entrepreneurial success. U.S. Patent No. 4,371,752 is just one of the more than thirty-three patents issued to Tulsa born and raised inventor and entrepreneur Gordon MatthewsRead more

    • Nautilus inventor created source of wealth and jobs

      By sarah | Comments are Closed

      By Scott Meacham The inventor of the Nautilus exercise machines created a source of wealth and jobs. Arthur A Jones, the inventor of Nautilus exercise machines, grew up in Seminole, OK. His father practiced medicine.Read more

    • Charles Machine Works a case study in entrepreneurship

      By sarah | Comments are Closed

      By Scott Meacham Charles Machine Works is a case study in entrepreneurship and innovation. To succeed in entrepreneurship, solve a problem that lots of businesses have. You can be even more successful, if the businessRead more

    • A real life success story in Ed Roberts and the Altair 8800

      By sarah | Comments are Closed

      By Scott Meacham Oklahoma State University alumni Ed Roberts is a real life success story with the invention of the Altair 8800 personal computer. About a third of i2E’s clients are in software/IT businesses. WeRead more

    Leave a Comment

    Cancel reply

    You must be logged in to post a comment.

    NextPrevious
    i2E-300dpi-Trans-Light
    • Events
    • News
    • Resources
    • Library
    • Love’s Cup

    Oklahoma City Office

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305
    Click HERE for printable map with directions.

    Tulsa Office

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592
    Click HERE for printable map with directions.
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • #withOklahomaStartups
    • #withOklahomaStartups
    • #withOklahomaStartups- copy
    • 2016 BrewFest
    • 2018 Paulsen Award Application
    • 2019 Business Plan Submittal Form
    • 2019 Intent to Compete
    • 2019 Oral Competition Submittal Form
    • 2019 Paulsen Award Application
    • 2020 Business Plan Submittal Form
    • 2020 Oral Competition Submittal Form
    • 2020 Paulsen Award Application
    • 2021 Official Application Form
    • 2021 Oral Competition Submittal Form
    • 2021 Paulsen Award Application
    • 4DSales
    • About
    • About i2E
    • About Us
    • ACT Tulsa
    • Add Listing
    • Alkami
    • Biolytx
    • BP Endo
    • Clear River Enviro
    • Concept Fund
    • Contact
    • COVID-19 News from i2E
    • COVID19 Resources for Scalable Startups
    • CreditPoint
    • Datebox
    • DermaMedics
    • DEX Pump
    • DigitalSix
    • Directory
    • Directory Dashboard
    • Docvia
    • Driven Analytics
    • e3
    • e3 Goes Virtual
    • e3: #withOklahomaStartups
    • Entrepreneurial Development
    • Entrepreneurial Summit
    • Entrepreneurial Summit Speakers
    • Entrepreneurs-in-Residence
    • Entrepreneurship
    • Events
    • Events
    • Exaptive
    • Exerbotics
    • Expert TA
    • Founder’s Book Nook
    • Home
    • Home
    • i2E Directory
    • i2E Events
    • iMCI
    • iMCI Investment Funds
    • Investments
    • iRecommend
    • Kirrhos
    • Letter from iMCI’s Executive in Residence in a time of great uncertainty
    • Library
    • Lifetone
    • Linear Health Sciences
    • Love’s Cup
      • Forms
      • High Growth
      • Paulsen Awards
      • Small Business
      • Timeline
    • Love’s Cup is Unstoppable
    • Love’s Cup W-9
    • MaxQ
    • Moleculera Labs
    • Monscierge
    • MS Pen Technologies
    • My Account
    • News
    • Newsletter
    • Newsletter Archive
    • OKBio
    • OKBio Directory
    • OMRF Glioblastoma
    • Otologics Pharmaceuticals
    • Past Winners
    • PhotoniCare
    • PolySkope Labs
    • Portfolio
    • Portfolio 3
    • Private Partners Opportunity Fund
    • Progentec Diagnostics
    • Q&A with Kevin Moore
    • Q&A with Michael Basch
    • Quarterly Report
    • Raw Space for Rent
    • Resources
    • Roll to Roll Technologies
    • Selexys Pharmaceuticals
    • Send a Ride
    • Simergent
    • Spiers New Technologies
    • Synercon Technologies
    • Tailwind
    • Ten Nine Technologies
    • Testimonials
    • Tetherex Pharmaceuticals
    • The Greg Main Distinguished Scholar Award
    • THG Energy Solutions
    • Thoughts from local business leaders and startup founders on the effects of COVID on their industry
    • Thoughts Post Shut In
    • Tulsa Collab: COVID-19 Efforts & Resources for Entrepreneurs
    • Tulsa GEW
    • Valve Systems International
    • Venture Advisory Services
    • Video
    • Virtuoso
    • Webmail Test Page
    • WeGoLook
    • Well Checked Systems
    • Whiteboard CRM
    i2E